Literature DB >> 11692075

GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase.

A C Blackburn1, M Coggan, H F Tzeng, H Lantum, G Polekhina, M W Parker, M W Anders, P G Board.   

Abstract

The zeta class glutathione transferases (GSTs) are known to catalyse the isomerization of maleylacetoacetate (MAA) to fumarylacetoacetate (FAA), and the biotransformation of dichloroacetic acid to glyoxylate. A new allele of human GSTZ1, characterized by a Thr82Met substitution and termed GSTZ1d, has been identified by analysis of the expressed sequence tag (EST) database. In European Australians, GSTZ1d occurs with a frequency of 0.16. Like GSTZ1b-1b and GSTZ1c-1c, the new isoform has low activity with dichloroacetic acid compared with GSTZ1a-1a. The low activity appears to be due to a high sensitivity to substrate inhibition. The maleylacetoacetate isomerase (MAAI) activity of all known variants was compared using maleylacetone as a substrate. Significant differences in activity were noted, with GSTZ1a-1a having a notably lower catalytic efficiency. The unusual catalytic properties of GSTZ1a-1a in both reactions suggest that its characteristic arginine at position 42 plays a significant role in the regulation of substrate access and/or product release. The different amino acid substitutions have been mapped on to the recently determined crystal structure of GSTZ1-1 to evaluate and explain their influence on function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692075     DOI: 10.1097/00008571-200111000-00005

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  15 in total

1.  Pattern of sequence variation across 213 environmental response genes.

Authors:  Robert J Livingston; Andrew von Niederhausern; Anil G Jegga; Dana C Crawford; Christopher S Carlson; Mark J Rieder; Sivakumar Gowrisankar; Bruce J Aronow; Robert B Weiss; Deborah A Nickerson
Journal:  Genome Res       Date:  2004-09-13       Impact factor: 9.043

Review 2.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

3.  Preliminary examination of polymorphisms of GSTM1, GSTT1, and GSTZ1 in relation to semen quality.

Authors:  Andrew F Olshan; Thomas J Luben; Nancy M Hanley; Sally D Perreault; Ronna L Chan; Amy H Herring; Patricia V Basta; David M DeMarini
Journal:  Mutat Res       Date:  2010-03-07       Impact factor: 2.433

4.  Prenatal and postnatal expression of glutathione transferase ζ 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetate.

Authors:  Wenjun Li; Yuan Gu; Margaret O James; Ronald N Hines; Pippa Simpson; Taimour Langaee; Peter W Stacpoole
Journal:  Drug Metab Dispos       Date:  2011-10-25       Impact factor: 3.922

5.  Organization and regulation of pentachlorophenol-degrading genes in Sphingobium chlorophenolicum ATCC 39723.

Authors:  Mian Cai; Luying Xun
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

6.  Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain.

Authors:  Kenneth P Cantor; Cristina M Villanueva; Debra T Silverman; Jonine D Figueroa; Francisco X Real; Monserrat Garcia-Closas; Nuria Malats; Stephen Chanock; Meredith Yeager; Adonina Tardon; Reina Garcia-Closas; Consol Serra; Alfredo Carrato; Gemma Castaño-Vinyals; Claudine Samanic; Nathaniel Rothman; Manolis Kogevinas
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

7.  Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases.

Authors:  Cindy E L Lim; Klaus I Matthaei; Anneke C Blackburn; Richard P Davis; Jane E Dahlstrom; Mark E Koina; M W Anders; Philip G Board
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 8.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

Review 9.  Role of dichloroacetate in the treatment of genetic mitochondrial diseases.

Authors:  Peter W Stacpoole; Tracie L Kurtz; Zongchao Han; Taimour Langaee
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

Review 10.  Cancer drugs, genetic variation and the glutathione-S-transferase gene family.

Authors:  Danyelle Townsend; Kenneth Tew
Journal:  Am J Pharmacogenomics       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.